14-64137874-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182914.3(SYNE2):​c.14734C>G​(p.Pro4912Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0366 in 1,614,114 control chromosomes in the GnomAD database, including 1,243 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.038 ( 146 hom., cov: 32)
Exomes 𝑓: 0.036 ( 1097 hom. )

Consequence

SYNE2
NM_182914.3 missense

Scores

7
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.01

Publications

15 publications found
Variant links:
Genes affected
SYNE2 (HGNC:17084): (spectrin repeat containing nuclear envelope protein 2) The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
ESR2 (HGNC:3468): (estrogen receptor 2) This gene encodes a member of the family of estrogen receptors and superfamily of nuclear receptor transcription factors. The gene product contains an N-terminal DNA binding domain and C-terminal ligand binding domain and is localized to the nucleus, cytoplasm, and mitochondria. Upon binding to 17beta-estradiol or related ligands, the encoded protein forms homo- or hetero-dimers that interact with specific DNA sequences to activate transcription. Some isoforms dominantly inhibit the activity of other estrogen receptor family members. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been fully characterized. [provided by RefSeq, Jul 2008]
ESR2 Gene-Disease associations (from GenCC):
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ovarian dysgenesis 8
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024898648).
BP6
Variant 14-64137874-C-G is Benign according to our data. Variant chr14-64137874-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130475.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0618 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE2NM_182914.3 linkc.14734C>G p.Pro4912Ala missense_variant Exon 79 of 116 ENST00000555002.6 NP_878918.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE2ENST00000555002.6 linkc.14734C>G p.Pro4912Ala missense_variant Exon 79 of 116 1 NM_182914.3 ENSP00000450831.2 Q8WXH0-2A0A0C4DGK3

Frequencies

GnomAD3 genomes
AF:
0.0383
AC:
5827
AN:
152116
Hom.:
147
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0411
Gnomad AMI
AF:
0.140
Gnomad AMR
AF:
0.0340
Gnomad ASJ
AF:
0.0288
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0124
Gnomad FIN
AF:
0.0494
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0396
Gnomad OTH
AF:
0.0398
GnomAD2 exomes
AF:
0.0329
AC:
8259
AN:
251326
AF XY:
0.0323
show subpopulations
Gnomad AFR exome
AF:
0.0413
Gnomad AMR exome
AF:
0.0213
Gnomad ASJ exome
AF:
0.0316
Gnomad EAS exome
AF:
0.000925
Gnomad FIN exome
AF:
0.0485
Gnomad NFE exome
AF:
0.0424
Gnomad OTH exome
AF:
0.0424
GnomAD4 exome
AF:
0.0365
AC:
53327
AN:
1461880
Hom.:
1097
Cov.:
31
AF XY:
0.0360
AC XY:
26165
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.0457
AC:
1531
AN:
33480
American (AMR)
AF:
0.0222
AC:
994
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0282
AC:
737
AN:
26136
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39700
South Asian (SAS)
AF:
0.0135
AC:
1166
AN:
86258
European-Finnish (FIN)
AF:
0.0459
AC:
2450
AN:
53420
Middle Eastern (MID)
AF:
0.0673
AC:
388
AN:
5768
European-Non Finnish (NFE)
AF:
0.0395
AC:
43901
AN:
1111998
Other (OTH)
AF:
0.0356
AC:
2149
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2994
5989
8983
11978
14972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1586
3172
4758
6344
7930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0383
AC:
5828
AN:
152234
Hom.:
146
Cov.:
32
AF XY:
0.0381
AC XY:
2833
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0411
AC:
1706
AN:
41522
American (AMR)
AF:
0.0340
AC:
520
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0288
AC:
100
AN:
3472
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5182
South Asian (SAS)
AF:
0.0126
AC:
61
AN:
4824
European-Finnish (FIN)
AF:
0.0494
AC:
524
AN:
10600
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0396
AC:
2695
AN:
68026
Other (OTH)
AF:
0.0394
AC:
83
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
285
570
854
1139
1424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0345
Hom.:
91
Bravo
AF:
0.0380
TwinsUK
AF:
0.0356
AC:
132
ALSPAC
AF:
0.0397
AC:
153
ESP6500AA
AF:
0.0397
AC:
175
ESP6500EA
AF:
0.0378
AC:
325
ExAC
AF:
0.0330
AC:
4003
Asia WGS
AF:
0.0140
AC:
49
AN:
3478
EpiCase
AF:
0.0407
EpiControl
AF:
0.0419

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 21, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Emery-Dreifuss muscular dystrophy 5, autosomal dominant Benign:3
Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
20
DANN
Benign
0.89
DEOGEN2
Benign
0.074
.;T;T;T;T
Eigen
Uncertain
0.29
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Benign
0.70
D
LIST_S2
Uncertain
0.92
D;D;D;D;D
MetaRNN
Benign
0.0025
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
M;.;M;.;.
PhyloP100
1.0
PrimateAI
Benign
0.38
T
PROVEAN
Uncertain
-3.4
D;.;D;D;D
REVEL
Benign
0.071
Sift
Uncertain
0.024
D;.;D;T;D
Sift4G
Uncertain
0.013
D;D;D;D;T
Polyphen
0.90
P;.;P;.;.
Vest4
0.19
MPC
0.18
ClinPred
0.040
T
GERP RS
4.0
Varity_R
0.17
gMVP
0.099
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17766354; hg19: chr14-64604592; API